| Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
Estimation | Confidence interval | Standardized estimation | P-value | Estimation | Confidence interval | Standardized estimation | P-value | |
Perceived self-efficacy | 0.12 | 0.1 to 0.14 | 0.37 |  < 0.001 | 0.005 | 0.03 to 0.06 | 0.22 |  < 0.001 |
Perceived susceptibility | − 0.016 | − 0.03 to 0.001 | − 0.06 | 0.067 | − 0.006 | − 0.02 to 0.01 | − 0.02 | 0.45 |
Perceived severity | − 0.02 | − 0.02 to 0.06 | 0.04 | 0.3 | 0.03 | − 0.002 to 0.06 | 0.065 | 0.068 |
Perceived barriers | − 0.21 | − 0.24 to − 0.19 | − 0.51 |  < 0.001 | − 0.14 | − 0.18 to − 0.11 | − 0.36 |  < 0.001 |
Perceived benefits | 0.2 | 0.17 to 0.23 | 0.4 |  < 0.001 | 0.07 | 0.03 to 0.11 | 0.14 | 0.001 |
Fatalism | − 0.4 | − 0.44 to − 0.34 | − 0.46 |  < 0.001 | − 0.16 | − 0.23 to − 0.09 | − 0.19 |  < 0.001 |
Cues to action | 0.025 | 0.009 to 0.04 | 0.11 | 0.002 | 0.01 | − 0.01 to 0.04 | 0.04 | 0.4 |
Recognition of clinical symptom of the disease | − 0.016 | − 0.1 to 0.06 | − 0.01 | 0.7 | 0.07 | 0.00 to 0.13 | 0.06 | 0.051 |
Gender = men–women | − 0.13 | − 0.086 to − 0.18 | − 0.2 |  < 0.001 | − 0.06 | − 0.08 to − 0.04 | − 0.42 |  < 0.001 |
Place of residence = urban–rural | − 0.09 | − 0.15 to 0.034 | − 0.11 | 0.002 | − 0.06 | 0.03 to 0.09 | 0.24 |  < 0.001 |
Age | − 0.01 | − 0.01 to 0.02 | − 0.02 | 0.55 | 0.001 | − 0.005 to 0.01 | − 0.014 | 0.76 |